pharmacogenetics Flashcards

1
Q

what is bioiformatics used for

A

looks at the differences in peoples genes by screening the sequnces

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

how often do SNPs occurs

A

every 300-1000 bps

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what two things cause genetic variations

A

SNP and CNV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

where do SNPs occur

A

anywhere in the genome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what might SNPS affect

A

stabilty, transcription/ translation, localisation and actiivty

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what does CNV affect

A

over 1000bp long segmnets of DNA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what affects genetic variation affects the genome more

A

CNV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what do CNVS do

A

chnage the number of gene copies which alters protein expression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

how are CNVs measured

A

take a control sample and a patinet of experimental sample
label them with differernt flurorphores
anylisis through floursence. DNA sequences will hybridize to differnet probes which consititue the whole genome
equal floursence means same amou t of copies, if one is more than others it will show that colour
once have the arrays can peice toegtehr the fragments of DNA and recontruct the chromosome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

how much does the genome conatin

A

around 3 billlion bp in haploid set of chromosomes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what did the huamn genome project tell us about single mendelain disorders

A
  • sickle cell anemia is an example
  • caustitive gene s
    -common and rare muatations
    -modifier genes/ polymorphisms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what did the human genome project tell us about common complex diseases

A
  • rheaumtiod arhtitis is the example
  • protective genes
    -pharamcogenetic variants
  • modifier genes/polymoprhisms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what are exmaples of harmless DNA varitaions

A

height and eye colour

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what disease is an example of a negative change in DNA

A

haemophilia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what is an exmaple of interplay between genes and enviroment

A

formaldehyde breaks down the BRCA1 tumour supressor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what is pharmacogenetics

A

the genetic basis for the individual vartiaon of drig responses (normally look at 1 or two genes)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what is metabolsim

A

chemical alteration of drug to aid excretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what are external factors

A

diet and exercise

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

what are internal factors

A

species, genetic make up, sex and age ect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

what is one size fits all pharmacology

A

some benefit while some may not, feuled by trail and error

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

how ineffective are antidepressants

A

up to 80%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

how ineffective are ACE ihibitors

A

for proteinuria and hypertesion
10-30%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

how ineffctive are beta blockers

A

cardiac
15-25%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

what is pharmacogenomics

A

the whole genome application of pharamgentic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

what are the aims of pharamgenomics

A
  • identify patients who will respond well
  • identify patients who will have adverse affect
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

how is pharmagenomics used in individualised medicine

A

use screening and patients stratificaton to look for specific SNPs associated with patient reponse

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

what are two exmaples of pharmacogenomics in individualise medicine

A
  • CYP450 variants for warafin therapy
  • factor V leiden mutataion before oral contraception
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

what are case contriol studies

A

healthy vs disease or normal drug response vs adverse drug reposne

29
Q

what are genome wide assocaition studies

A

compare large populations to ID fucntionally important SNPs or combnation SNPs (can also look at CNVs)

30
Q

what are the promises of pharmacyogenomics

A
  • improved drugs choses
  • safer doses
  • improvement in drug devlopement
  • decreased health care costs
31
Q

what is the issue with primaquine

A

if you have a g-6-pd defiency causes heamolysis of red blood cells and anemia. Primaquine is an oxidant and causing damage through ROS whihc reduced gluathione would normally protect against.

32
Q

where are there higher rates of G-6-PD defiency

A

in malaria high high countries there are reports that suggest it could give protection

33
Q

give exmaples of anti malrai druhgs

A

primaquine
sulfanilamide

34
Q

what is pharmakinetic varation

A

variation affecting drug metabolism/ transport (ADME)

35
Q

what is pharmadynamic varation

A

varitaion affecting drug targets or assocaited pathways

36
Q

what is the rare and unpredictable genetic variatoin

A

variation associated with idiosynthric pathways not related to the pharmacological properties of the drug usually immune mediated

37
Q

what drug has to be metabolized to become cytotoxic

A

cyclophophamide is non toxic but when metaboilsied by CYP2B6 becoes cytotoxic

38
Q

what needs to be considered in pharamkinetic varitation

A
  • is parent or metabolite active
  • is genetic varaint causing an increase or decrease activtity
39
Q

what does therpautic affect depend on

A

whetehr parent or metaolite is active

40
Q

what is phase I metabolism

A

addition of functional groups making metabolites more polar

41
Q

what reactions take place in phase I metbolims and which one the most

A

hydrolysis, oxidation and reduction
oxidation most common by CYP450

42
Q

what does phase I normally do

A

inactivate the drug

43
Q

what happens to the product after phase I metbaolism

A

normally undergoes conjugation in pahse II

44
Q

what does phase II include

A

sulphataion, glucuronidation, acteylation, conjugation to gluathiane

45
Q

what does phase II produce

A

highly polar molecules ready for excreation, usaullly inactivates drugs

46
Q

what drug does pahse II activate

A

morphin 6 glucorinide

47
Q

what defect causes paralysis with suucinylcholine and what is SCC used for

A

used in theatre for incubation
defect in butyrylcholinesterase can cause paralysis and repiratory faliure

48
Q

what are the different variruanst of BCHE defeiciney

A

heterozygous- prolonged paralysis (3-4x)
homozygous- prolonged paraylsis (3-4 hrs)
Silent variant- associated with no cholinesterase activity from truncating mutations

49
Q

what are the two enzymes involved in alchohol metabolsim

A

alcohol dehydrogenase (ADH)
aldehyde dehyrodgase (ALDH)
tehy exhibit genetic heterogenity
there are multiple variants in both

50
Q

what variant causes lower levels of ahcoholism

A

ADH1B*2 more active so quickly conmverts ethanol into toxic alcytaldehyde

51
Q

what variant causes head and neck cancer from drinking

A

ALDH2*2 is loss of activty leading to toxic levels of acetaldehyde detected in the saliva

52
Q

how big is the superfamilt for cyp450

A

57 genes

53
Q

where is CYP450 mainlyt expressed

A

liver and GI tract

54
Q

what are the three main families of cyp450

A

cyp1, cyp2 and cyp3

55
Q

what is needed to convert codine to morphine

A

CYP2D6

56
Q

CYP2C19

A

decreased and 0 actiivty alleles,
metabolises antidepressants

57
Q

what enzyme metabolises antidepressanyts

A

CYP2C19

58
Q

CYP2C9

A

increased, decreased and 0 activity alleles, metabolises warfrin

59
Q

what enzyme meatbolsies warafrin

A

CY2C9

60
Q

CYP2D6

A

increased, decreased and zero activity
metabolsies nortryptilline

61
Q

what causes ultra rapid metabolism

A

gene amplification

62
Q

what metabolsies nortryptilline

A

CYP2D6

63
Q

for the genotype-phenotype relationship of CY2D6 what is the normal genotype

A

extensive metabolisms

64
Q

what does CY2D6 activate

A

codine to morphine

65
Q

what does CYP2D6 inactitivate

A

nortriptyline

66
Q

what is the p450 CYP chip reposible for

A

used to dtermine genotypes for alleles of selevetd cyp genes

67
Q

how do you test acetylator status

A

sulfadomide

68
Q

what does tmpt affect

A

the metabolsim of thioguanine and azothipurine
low TMPT leads to increased toxicity and seondary neoplasm
high TMPT leads to decreased therpautic affect